DPDoctor's PassportEducation
Psychiatry indexPassport
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Textbook/Psychiatry/Long-term relapse prevention/Rapid
RapidMLAMSRAFoundationGP

Long-term relapse prevention

Essential points for quick revision.

2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Relapse prevention plan has failed

New suicidal intent, psychosis, near-total sleep loss, escalating spending or aggression, severe self-neglect or mixed activation means the person needs urgent episode assessment rather than a routine maintenance appointment.

Action: Activate the agreed crisis pathway, assess physical state and specific harm scenarios, reduce access to relevant means and contact specialist services directly. Review adherence, recent medication changes and substances, protect dependants and arrange the least restrictive safe care setting.

Synopsis

Build individual relapse prevention after each bipolar episode using lithium-first pharmacology, structured psychological treatment, physical-health protection and a written plan for early warning signs, medication change and safe discontinuation.

  • After every manic or bipolar depressive episode, review long-term prevention, previous consequences, residual symptoms, effective treatments, patient priorities and reproductive plans.
  • Offer a structured individual, group or family psychological intervention designed for bipolar disorder to prevent relapse or address persisting inter-episode symptoms.
  • First-line long-term pharmacological treatment is lithium; NICE explains that it is the most effective maintenance medicine for bipolar disorder.

Key red flags

A rapid fall in sleep need with increasing energy, speech or spending can precede mania and requires prompt use of the agreed escalation plan.

Investigation priorities

01
Episode and consequence reviewFirst step

Map polarity, frequency, severity, triggers, harms, recovery and previous treatment response across the illness.

Management branches

First-line pharmacological preventionOffer monitored lithium treatment

Long-term medication is being planned after a bipolar episode and lithium is acceptable and clinically suitable.

  1. Discuss episode history, lithium's relative long-term effectiveness, monitoring burden, toxicity, interactions, pregnancy implications and the person's priorities.
  2. Complete baseline tests, establish specialist initiation and shared-care responsibilities and titrate to a guideline target using correctly timed plasma levels.
Planned discontinuationTaper and monitor beyond the last dose

A stable patient makes an informed decision to stop long-term pharmacological treatment.

Key medicines

Lithium carbonate prolonged-releaseInitiate only with specialist and shared-care monitoring; individualise the oral dose to a correctly timed plasma concentration, usually aiming for 0.6 to 0.8 mmol/L when lithium is prescribed for the first time.
Aripiprazole oralFor recurrence prevention after a manic episode that responded to aripiprazole, continue the same once-daily dose; adult manic treatment commonly starts at 15 mg daily and must not exceed 30 mg daily.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom